This document provides guidelines for experience meetings and dinner debates aimed at doctors to discuss the drug Zelmac. The objectives are to share positive experiences with Zelmac to gain doctors' confidence, discuss ways to better identify IBS-C patients, and encourage doctors to prescribe Zelmac for more patients. Meetings should have 6-7 minimum attendees, at least 70% of whom have positive Zelmac experience. Moderators must be gastroenterologists who advocate for Zelmac and have excellent presentation skills. Meetings will follow a case study approach, with representatives following up after to evaluate changes in doctors' attitudes and prescribing habits.